COVID-19 in patients with systemic lupus erythematosus: A systematic review

Xue-Lei Fu1, Yan Qian2, Xiao-Hong Jin2

  • 1School of Medicine, 66479Nantong University, Nantong, Jiangsu, China.

Lupus
|April 6, 2022
PubMed

Insights

Systemic lupus erythematosus (SLE) patients with COVID-19 experienced challenges in healthcare access and psychological distress. Hydroxychloroquine did not prevent COVID-19 in these patients.

Area of Science:

  • Rheumatology
  • Infectious Diseases
  • Epidemiology

Background:

  • Systemic lupus erythematosus (SLE) is an autoimmune disease.
  • Coronavirus disease 2019 (COVID-19) is a global pandemic.
  • Understanding the intersection of SLE and COVID-19 is crucial for patient care.

Purpose of the Study:

  • To review the epidemiology of SLE and COVID-19.
  • To identify clinical characteristics and treatment of COVID-19 in SLE patients.
  • To assess the pandemic's impact on SLE patients' health and healthcare access.

Main Methods:

  • Systematic literature review of PubMed.
  • Inclusion criteria: human studies on COVID-19 in SLE patients, published Dec 2019-June 2021.
  • 52 studies were included in the review.

Main Results:

  • COVID-19 prevalence in SLE patients ranged from 0.0% to 18.1%; hospitalization rates were 0.24% to 10.6%.
  • COVID-19 infection can mimic SLE flares.
  • Hydroxychloroquine was ineffective for COVID-19 prevention; patients faced healthcare access issues, financial strain, and psychological distress.

Conclusions:

  • The COVID-19 pandemic significantly impacted SLE patients' mental and physical health.
  • Adequate healthcare access, containment policies, and psychological support are essential for managing SLE patients during pandemics.
  • COVID-19 management in SLE requires careful consideration of disease-specific factors and patient well-being.

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
32
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
94
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
46
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
41
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
62
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
711